BriaCell Therapeutics (BCT) Competitors C$1.07 -0.03 (-2.73%) (As of 11/4/2024 05:19 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarnings BCT vs. ONC, SCYB, COM, NVH, COV, IGX, SVA, TH, PDP, and EMHShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include Oncolytics Biotech (ONC), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), Covalon Technologies (COV), IntelGenx Technologies (IGX), Sernova (SVA), Theratechnologies (TH), Pediapharm (PDP), and Emerald Health Therapeutics (EMH). These companies are all part of the "biotechnology" industry. BriaCell Therapeutics vs. Oncolytics Biotech Scythian Biosciences 138267 (COM.TO) Novoheart Covalon Technologies IntelGenx Technologies Sernova Theratechnologies Pediapharm Emerald Health Therapeutics BriaCell Therapeutics (TSE:BCT) and Oncolytics Biotech (TSE:ONC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their community ranking, analyst recommendations, dividends, institutional ownership, profitability, risk, media sentiment, valuation and earnings. Is BCT or ONC more profitable? Oncolytics Biotech's return on equity of -138.22% beat BriaCell Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets BriaCell TherapeuticsN/A -206.01% -122.71% Oncolytics Biotech N/A -138.22%-71.33% Which has better valuation & earnings, BCT or ONC? Oncolytics Biotech is trading at a lower price-to-earnings ratio than BriaCell Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBriaCell TherapeuticsN/AN/A-C$6M-C$0.50-2.14Oncolytics BiotechN/AN/A-C$28.02M-C$0.38-4.21 Do analysts rate BCT or ONC? Oncolytics Biotech has a consensus target price of C$3.50, indicating a potential upside of 118.75%. Given Oncolytics Biotech's higher possible upside, analysts plainly believe Oncolytics Biotech is more favorable than BriaCell Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BriaCell Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AOncolytics Biotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in BCT or ONC? 15.0% of BriaCell Therapeutics shares are owned by institutional investors. Comparatively, 1.8% of Oncolytics Biotech shares are owned by institutional investors. 9.3% of BriaCell Therapeutics shares are owned by company insiders. Comparatively, 3.8% of Oncolytics Biotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the MarketBeat Community prefer BCT or ONC? Oncolytics Biotech received 195 more outperform votes than BriaCell Therapeutics when rated by MarketBeat users. However, 100.00% of users gave BriaCell Therapeutics an outperform vote while only 75.10% of users gave Oncolytics Biotech an outperform vote. CompanyUnderperformOutperformBriaCell TherapeuticsOutperform Votes1100.00% Underperform VotesNo VotesOncolytics BiotechOutperform Votes19675.10% Underperform Votes6524.90% Does the media prefer BCT or ONC? In the previous week, BriaCell Therapeutics had 1 more articles in the media than Oncolytics Biotech. MarketBeat recorded 2 mentions for BriaCell Therapeutics and 1 mentions for Oncolytics Biotech. BriaCell Therapeutics' average media sentiment score of 3.00 beat Oncolytics Biotech's score of 0.75 indicating that BriaCell Therapeutics is being referred to more favorably in the media. Company Overall Sentiment BriaCell Therapeutics Very Positive Oncolytics Biotech Positive Which has more volatility & risk, BCT or ONC? BriaCell Therapeutics has a beta of 1.83, indicating that its share price is 83% more volatile than the S&P 500. Comparatively, Oncolytics Biotech has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. SummaryBriaCell Therapeutics beats Oncolytics Biotech on 8 of the 14 factors compared between the two stocks. Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCT vs. The Competition Export to ExcelMetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$38.35MC$189.78MC$5.09BC$4.71BDividend Yield13.70%3.48%7.52%6.56%P/E Ratio-2.14342.67135.8825.96Price / SalesN/A21,497.471,688.511,289.64Price / CashN/A11.1937.1978.98Price / Book-2.896.934.613.15Net Income-C$6M-C$19.41MC$116.08MC$268.46M7 Day Performance-9.32%0.55%-0.97%0.16%1 Month Performance-20.74%2.07%5.32%1.53%1 Year Performance-82.02%23.03%33.75%41.34% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTBriaCell TherapeuticsN/AC$1.07-2.7%N/A-82.0%C$38.35MN/A-2.1416Positive NewsONCOncolytics Biotech1.5427 of 5 starsC$1.60-3.6%C$3.50+118.8%-31.9%C$122.98MN/A-4.2129SCYBScythian BiosciencesN/AC$3.49-5.9%N/A+0.0%C$102.38MN/A0.00N/AHigh Trading VolumeCOM138267 (COM.TO)N/AN/AN/AN/AC$102.19MN/A0.00N/ANVHNovoheartN/AC$0.53+1.9%N/A+0.0%C$99.98MC$423,500.00-13.95N/ACOVCovalon TechnologiesN/AC$3.44flatN/A+175.2%C$94.26MC$29.20M-86.00N/AIGXIntelGenx TechnologiesN/AC$0.58+1.8%N/A+0.0%C$87.32MC$1.75M-7.442,050Gap UpSVASernova2.0104 of 5 starsC$0.25flatC$1.83+633.3%-68.8%C$81.33MN/A-1.921,959Gap UpTHTheratechnologiesN/AC$1.69+0.6%N/A-6.1%C$77.71MC$82.57M-9.39103Gap DownHigh Trading VolumePDPPediapharmN/AC$0.30+1.7%N/A+0.0%C$66.36MC$11.16M-4.11N/AEMHEmerald Health TherapeuticsN/AC$0.26-3.8%N/A+0.0%C$52.28MC$13.02M-0.37161 Related Companies and Tools Related Companies ONC Alternatives SCYB Alternatives COM Alternatives NVH Alternatives COV Alternatives IGX Alternatives SVA Alternatives TH Alternatives PDP Alternatives EMH Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:BCT) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCT Stock Alerts